The Democratic Republic of the Congo (DRC) is currently battling an escalating outbreak of the Bundibugyo variant of the Ebola virus, with 808 confirmed cases and 192 deaths reported as of late June 2026. The World Health Organization (WHO) has designated the situation a public health emergency of international concern, as the virus spreads across the eastern province of Ituri and into neighboring Uganda, according to official health authorities.
Why is the Bundibugyo variant spreading so quickly?
While the Bundibugyo strain typically exhibits lower transmission rates than other Ebola variants, the current outbreak is moving at an “alarming speed” due to a lack of rapid diagnostic infrastructure, according to the U.S. Centers for Disease Control and Prevention (CDC). Experts note that the crisis is exacerbated by regional instability, which limits the ability of health teams to track contacts. Data from Médecins Sans Frontières (MSF) shows that contact tracing coverage has dropped significantly, falling from 79% during the 2018 outbreak to just 43% in June 2026.
How are international funding cuts impacting the response?
Humanitarian aid for the DRC has plummeted by 46% over the past two years, falling from 2.22 billion euros in 2024 to 1.4 billion euros in 2026, as reported by Oxfam Intermón. This reduction follows the 2025 decision by the U.S. administration to dismantle the United States Agency for International Development (USAID), which previously accounted for 42% of total international funding. The lack of resources has forced organizations to scale back community outreach, leaving a void that is increasingly filled by dangerous misinformation and public distrust.
When will a vaccine be available for the Bundibugyo strain?
There is currently no authorized vaccine or treatment specifically for the Bundibugyo variant, a major departure from previous Ebola responses. Richard Hatchett, director of the Coalition for Epidemic Preparedness Innovations (CEPI), stated that vaccine candidates from the University of Oxford and Moderna could enter Phase 1 clinical trials by July 2026. However, field testing is not expected to begin for several months, leaving frontline health workers to rely on traditional containment measures during the interim.
| Metric | 2018 Outbreak | 2026 Outbreak |
|---|---|---|
| Contact Tracing Coverage | 79% | 43% |
What role does infrastructure play in containing the virus?
Clean water and basic sanitation are the primary defenses against the virus, yet access remains dire. Oxfam Intermón reports that only one in five health centers in Ituri has sufficient access to potable water. In cities like Mongbwalo, where 140,000 people reside, only 20% of the population has access to clean water. This shortage forces families to pay two dollars for twenty liters of water, a cost that remains prohibitively expensive for most, according to Manel Rebordosa, coordinator of the Oxfam response in Ituri.
Frequently Asked Questions
- Is Ebola spread through the air or water? No. According to health experts, Ebola is not transmitted via air or water, though clean water is essential for the hygiene required to prevent secondary infections.
- Why is it harder to track this outbreak compared to 2018? Lower funding and the presence of armed groups, such as the M23, have restricted access to affected areas and reduced the effectiveness of contact tracing teams.
- Are there any treatments available? Currently, there is no approved treatment for the Bundibugyo variant, though clinical trials for new vaccines are expected to begin in mid-2026.
The humanitarian crisis in the DRC requires urgent international attention. To learn more about how you can support local health initiatives or to stay updated on the latest developments in the region, subscribe to our global health newsletter here.
